FAS and neoplasm: Different mechanisms of action might be responsible for a delay in tumor growth: Some antibodies (i.e., anti-CD95 mAb or bispecific anti-CD95) directly target apoptosis receptors and kill the tumor cells through apoptosis [80,81].